Caption Management’s Seres Therapeutics MCRB Stock Holding History

Caption Management’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-75,000	Closed	-$1.12M	–	1864
2025 Q4	$1.12M	Hold	75,000	–	–	0.01%	1023
2025 Q3	$1.44M	Buy	+75,000	New	+$1.2M	0.01%	970
2023 Q4	–	Sell	-2,500	Closed	-$119K	–	1532
2023 Q3	$119K	Buy	+2,500	New	+$191K	﹤0.01%	1141
2023 Q2	–	Sell	-2,000	Closed	-$227K	–	1285
2023 Q1	$227K	Buy	+2,000	New	+$216K	﹤0.01%	908
2022 Q4	–	Sell	-2,500	Closed	-$321K	–	1543
2022 Q3	$321K	Hold	2,500	–	–	﹤0.01%	1165
2022 Q2	$172K	Sell	2,500 -5,000	-67%	-$431K	﹤0.01%	1255
2022 Q1	$1.07M	Buy	+7,500	New	+$1.15M	0.01%	951
2021 Q4	–	Sell	-3,500	Closed	-$487K	–	1802
2021 Q3	$487K	Sell	3,500 -5,860	-63%	-$1.15M	0.01%	1203
2021 Q2	$4.46M	Buy	9,360 +6,620	+242%	+$2.79M	0.06%	398
2021 Q1	$1.13M	Buy	+2,740	New	+$1.26M	0.02%	656
2020 Q4	–	Sell	-16,905	Closed	-$9.57M	–	1151
2020 Q3	$9.57M	Buy	+16,905	New	+$5.62M	0.22%	98

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caption Management's MCRB Position: Q4 2023 in Review

Caption Management sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 381 shares — an estimated $18.1K sold.

Caption Management first reported a position in MCRB in Q2 2020 and held it in 4 quarters. The position peaked at $1.5M in Q2 2021. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

Caption Management reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
Caption Management sold 381 Seres Therapeutics shares in Q4 2023, an estimated $18.1K.
Caption Management first reported a position in Seres Therapeutics in Q2 2020 and held it in 4 quarters.
Caption Management's Seres Therapeutics position peaked at $1.5M in Q2 2021.
102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Caption Management's 13F filing for Q4 2023, filed 14 Feb 2024.